Investing in virology and immunology research to discover new methods to prevent, treat, and cure virus-related disease.
The Li Ka Shing Institute of Virology is dedicated to advancing global health through pioneering research in virology and immunology. Located in Edmonton, Alberta, at 6-010 Katz Group Centre for Pharmacy and Health Research, 87 Ave and 112 Street, the institute focuses on discovering innovative methods to prevent, treat, and cure virus-related diseases. By investing in cutting-edge research and fostering international collaborations, the Li Ka Shing Institute of Virology strives to reduce the burden of viral diseases worldwide.
The Li Ka Shing Institute of Virology unites a consortium of exemplary researchers affiliated with numerous departments and faculties. The institute's success is built upon strong intra- and inter-collegiate connections, including collaborations with institutes across Canada and numerous countries globally. Research interests encompass viral pathogenesis, vaccine development, correlates of immunity, enhancement of vaccine efficacy, oncolysis, and the development of novel antivirals.
The Li Ka Shing Institute of Virology is committed to making a significant impact on human health around the world through its research and collaborative efforts. The institute's dedication to scientific excellence and innovation positions it as a leader in the field of virology and immunology. We invite the management of the Li Ka Shing Institute of Virology to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.
L'Institut de virologie Li Ka Shing se consacre à l'avancement de la santé mondiale grâce à une recherche novatrice en virologie et en immunologie. Situé à Edmonton, Alberta, au 6-010 Katz Group Centre for Pharmacy and Health Research, 87 Ave et 112 Street, l'institut se concentre sur la découverte de méthodes novatrices pour prévenir, traiter et guérir les maladies liées aux virus. En investissant dans la recherche de pointe et en favorisant les collaborations internationales, l'Institut de virologie Li Ka Shing s'efforce de réduire le fardeau des maladies virales dans le monde entier.
L'Institut de virologie Li Ka Shing réunit un consortium de chercheurs exemplaires affiliés à de nombreux départements et facultés. Le succès de l'institut repose sur des liens intra- et intercollégiaux solides, y compris des collaborations avec des instituts à travers le Canada et de nombreux pays à l'échelle mondiale. Les intérêts de recherche englobent la pathogenèse virale, le développement de vaccins, les corrélats de l'immunité, l'amélioration de l'efficacité des vaccins, l'oncolyse et le développement de nouveaux antiviraux.
L'Institut de virologie Li Ka Shing s'engage à avoir un impact significatif sur la santé humaine dans le monde entier grâce à ses efforts de recherche et de collaboration. Le dévouement de l'institut à l'excellence scientifique et à l'innovation le positionne comme un chef de file dans le domaine de la virologie et de l'immunologie. Nous invitons la direction de l'Institut de virologie Li Ka Shing à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en valeur son travail novateur.
Compare Li Ka Shing Institute of Virology with 3 companies in Research-Services
| Comparison Field |
Li Ka Shing Institute of...Main Company |
Mahdia TebView Profile |
TSTrialsView Profile |
Virology Research Se...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2005 | 2016 | 2017 |
|
Company Size
|
— | 11-50 | 1,001-5,000 | 2-10 |
|
City
|
Edmonton, Alberta | Sittingbourne, Kent | ||
|
Country
|
Canada | United Kingdom | ||
|
Skills & Keywords
Comparing with main company
|
26 Total Skills
Virology Research
Immunology Research
Vaccine Development
Antiviral Research
Viral Pathogenesis
Disease Prevention
Global Health
Human Immunodeficiency Virus
Respiratory syncytial virus
Influenza viruses
Zika virus
Virology
Hepatitis B & C viruses
COVID-19
Vaccines
West Nile virus
Herpesviruses
Pox viruses
Immunology
Rubella virus
Oncolysis
Flaviviruses
Dengue virus
SARS-CoV-2
Antivirals
Reovirus
|
4 Total
4 Unique
Unique Skills:
Genetics
Laboratory Diagnostics
Microbiology
Molecular Biology
|
7 Total
7 Unique
Unique Skills:
Clinical Trials
Infectious Disease
Metabolic Disorders
Oncology
Rare Disease
Respiratory Disease
+1
|
17 Total
17 Unique
Unique Skills:
Air-Liquid Interface
Assay Development
CMV
Dengue
DNA & RNA viruses
Drug Discovery
+11
|
Other organizations in the same industry
This company is also known as